Smartlab Europe

News

Aware Gleneagles Global Hospital commemorates World Physiotherapy Day

Physiotherapy or Physical Therapy helps people recover from an injury, relieve pain, prevent future injury, or deal with a chronic condition; and now it has been noticed that it helps people overcome the after-effects of Covid-19 infections or related...

Ardena acquires Idifarma from Suanfarma and Sodena, adding spray drying technology and high potency capabilities

Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organisation (CDMO), has announced that it has acquired Idifarma, a leading Contract Manufacturer of niche and highly potent generic and innovative drugs. The acquisition from Suanfarma delivers expansion across Southern Europe and...

Quanticate appoints new Head of Machine Learning and Digital Transformation

Quanticate, a leading global data-focused Clinical Research Organization (CRO), has named Piotr Karasiewicz as the company's new Head of Machine Learning and Digital Transformation to lead process improvements and ensure efficient and high-quality data analysis. Reporting to Quanticate's Chairman and...

The Zantac Lawsuit: 3 Lessons For The Drug Industry

Some histamine-2 receptor blocker medications like Zantac were initially ruled out as safe by the FDA. It was a drug for patients who experience heartburn and other gastrointestinal illnesses. Individuals with gastroesophageal reflux disease (GERD) and excessive stomach acid...

Code Pharma BV: Antiviral Drug Codivir Shows Promising Effect Against COVID-19

Codivir, a short synthetic 16 amino-acid peptide, derived from the HIV-1 integrase, was originally discovered at the Hebrew University in Israel. Code Pharma discovered that the peptide had a direct antiviral effect against SARS-CoV-2, the novel Coronavirus causing COVID-19. In-vitro...

NRx’s Zyesami lowers respiratory distress in Phase IIb/III Covid-19 trial

NRx Pharmaceuticals has reported additional data from Phase IIb/III clinical trial where its drug, Zyesami (aviptadil), offered a rise in blood oxygen within a day in critical Covid-19 patients with acute respiratory failure. Zyesami is a synthetic form of vasoactive...

Virpax Inks MMS019 Manufacturing and Supply Agreement

Virpax Pharmaceuticals, a company specializing in developing product candidates for pain management, CNS and anti-viral indications, has entered into a commercial manufacturing and supply agreement with Seqens, an integrated global leader in pharmaceutical solutions with 24 manufacturing sites worldwide...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »